BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,737,726 | -6.8% | 280,155 | +18.7% | 0.00% | -25.0% |
| Q2 2023 | $7,227,024 | 0.0% | 236,023 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,227,024 | -25.6% | 236,023 | -5.0% | 0.00% | -20.0% |
| Q4 2022 | $9,718,952 | -99.7% | 248,503 | +322.7% | 0.01% | +150.0% |
| Q3 2022 | $2,800,756,000 | +10.7% | 58,790 | -10.1% | 0.00% | +100.0% |
| Q2 2022 | $2,530,395,000 | -1.4% | 65,368 | +46.0% | 0.00% | 0.0% |
| Q1 2022 | $2,565,722,000 | -20.4% | 44,777 | +10.7% | 0.00% | 0.0% |
| Q4 2021 | $3,224,257,000 | -6.5% | 40,460 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $3,449,076,000 | -29.0% | 39,640 | +5.0% | 0.00% | -50.0% |
| Q2 2021 | $4,858,030,000 | +234.4% | 37,744 | +107.9% | 0.00% | +100.0% |
| Q1 2021 | $1,452,807,000 | +36.5% | 18,151 | +39.2% | 0.00% | – |
| Q4 2020 | $1,064,422,000 | – | 13,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |